Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Burden of human papillomavirus-related cervical disease in the extended middle East and north Africa-a comprehensive literature review.

Seoud M.

J Low Genit Tract Dis. 2012 Apr;16(2):106-20. doi: 10.1097/LGT.0b013e31823a0108. Review.

PMID:
22371041
2.

Burden of human papillomavirus infections and related diseases in the extended Middle East and North Africa region.

Vaccarella S, Bruni L, Seoud M.

Vaccine. 2013 Dec 30;31 Suppl 6:G32-44. doi: 10.1016/j.vaccine.2012.06.098. Review.

PMID:
24331818
3.

Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).

Kim JJ, Sharma M, O'Shea M, Sweet S, Diaz M, Sancho-Garnier H, Seoud M.

Vaccine. 2013 Dec 30;31 Suppl 6:G65-77. doi: 10.1016/j.vaccine.2012.06.096.

PMID:
24331822
4.

Global burden of human papillomavirus and related diseases.

Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S.

Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055. Review.

PMID:
23199955
5.

Overview of cervical cancer screening practices in the extended Middle East and North Africa countries.

Sancho-Garnier H, Khazraji YC, Cherif MH, Mahnane A, Hsairi M, El Shalakamy A, Osgul N, Tuncer M, Jumaan AO, Seoud M.

Vaccine. 2013 Dec 30;31 Suppl 6:G51-7. doi: 10.1016/j.vaccine.2012.06.046. Review.

PMID:
24331820
6.

Spectrum of genital human papillomavirus infection in a female adolescent population.

Jamison JH, Kaplan DW, Hamman R, Eagar R, Beach R, Douglas JM Jr.

Sex Transm Dis. 1995 Jul-Aug;22(4):236-43.

PMID:
7482107
7.

Male circumcision and genital human papillomavirus: a systematic review and meta-analysis.

Albero G, Castellsagué X, Giuliano AR, Bosch FX.

Sex Transm Dis. 2012 Feb;39(2):104-13. doi: 10.1097/OLQ.0b013e3182387abd. Review.

PMID:
22249298
8.

Human papillomavirus: the burden of infection.

Wiley D, Masongsong E.

Obstet Gynecol Surv. 2006 Jun;61(6 Suppl 1):S3-14. Review.

PMID:
16729902
9.

Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.

Chelimo C, Wouldes TA, Cameron LD, Elwood JM.

J Infect. 2013 Mar;66(3):207-17. doi: 10.1016/j.jinf.2012.10.024. Epub 2012 Oct 26. Review.

PMID:
23103285
10.

Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection.

Brisson M, Van de Velde N, De Wals P, Boily MC.

CMAJ. 2007 Aug 28;177(5):464-8. Epub 2007 Aug 20.

11.

Epidemiology and natural history of genital human papillomavirus infection.

Weaver BA.

J Am Osteopath Assoc. 2006 Mar;106(3 Suppl 1):S2-8. Review.

PMID:
16729554
12.

Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy.

Brotherton JM, Kaldor JM, Garland SM.

Sex Health. 2010 Sep;7(3):310-9. doi: 10.1071/SH09137.

PMID:
20719220
13.

The burden of human papillomavirus infections and related diseases in sub-saharan Africa.

De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP.

Vaccine. 2013 Dec 29;31 Suppl 5:F32-46. doi: 10.1016/j.vaccine.2012.07.092. Review.

14.

[Knowledge of HPV-related genital lesions and of anti-HPV vaccination in a sample of women of north-eastern Italy].

Sopracordevole F, Cigolot F, Lucia E, Marchesoni D.

Minerva Ginecol. 2009 Apr;61(2):81-7. Italian.

PMID:
19255555
15.
16.

Prevalence and risk factors for human papillomavirus DNA in cervical cytology.

Kasap B, Yetimalar H, Keklik A, Yildiz A, Cukurova K, Soylu F.

Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):168-71. doi: 10.1016/j.ejogrb.2011.06.021. Epub 2011 Jul 18.

PMID:
21764503
17.

Population impact of HPV vaccines: summary of early evidence.

Hariri S, Markowitz LE, Dunne EF, Unger ER.

J Adolesc Health. 2013 Dec;53(6):679-82. doi: 10.1016/j.jadohealth.2013.09.018. Review.

PMID:
24263069
18.

Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study.

Van Doornum GJ, Prins M, Juffermans LH, Hooykaas C, van den Hoek JA, Coutinho RA, Quint WG.

Genitourin Med. 1994 Aug;70(4):240-6.

19.

Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel: accounting for CIN1 and genital warts in addition to CIN2/3 and cervical cancer.

Shavit O, Raz R, Stein M, Chodick G, Schejter E, Ben-David Y, Cohen R, Arbel D, Shalev V.

Appl Health Econ Health Policy. 2012 Mar 1;10(2):87-97. doi: 10.2165/11594780-000000000-00000.

PMID:
22201263
20.

Risk factors for cervical neoplasia in Denmark.

Kjaer SK.

APMIS Suppl. 1998;80:1-41.

PMID:
9693662

Supplemental Content

Support Center